COVID-19: FDA withdraws approval for AstraZeneca’s medication
The United States Food and Drug Administration has withdrawn emergency-use permission for AstraZeneca's COVID-19 antibody cocktail Evusheld because the medication is unlikely to neutralize the currently prevalent XBB.1.5 subvariant of…